SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-21-001374
Filing Date
2021-04-14
Accepted
2021-04-14 12:42:20
Documents
38
Period of Report
2021-02-28

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT cannabics_10q-022821.htm 10-Q 360594
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER cannabics_ex3101.htm EX-31.1 9783
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER cannabics_ex3102.htm EX-31.2 9865
4 CERTIFICATION cannabics_ex3201.htm EX-32.1 5133
5 CERTIFICATION cannabics_ex3202.htm EX-32.2 4879
6 GRAPHIC image_003.gif GRAPHIC 9610
7 GRAPHIC image_004.jpg GRAPHIC 14351
8 GRAPHIC image_005.jpg GRAPHIC 25952
9 GRAPHIC image_006.jpg GRAPHIC 41968
  Complete submission text file 0001683168-21-001374.txt   1323695

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE cnbx-20210228.xml EX-101.INS 91675
11 XBRL SCHEMA FILE cnbx-20210228.xsd EX-101.SCH 12356
12 XBRL CALCULATION FILE cnbx-20210228_cal.xml EX-101.CAL 27888
13 XBRL DEFINITION FILE cnbx-20210228_def.xml EX-101.DEF 21992
14 XBRL LABEL FILE cnbx-20210228_lab.xml EX-101.LAB 111896
15 XBRL PRESENTATION FILE cnbx-20210228_pre.xml EX-101.PRE 81198
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52403 | Film No.: 21825122
SIC: 2834 Pharmaceutical Preparations